Answers are grounded in this paper and cite their sources.
Real-life data show that treatment with Zomacton® improves auxological outcome parameters without new safety concerns. NF administration of GH represents a useful alternative to NI in children with growth disorders.
No takes yet. Share an insight, caveat, or question.
Rohrer et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: